# Pharmacokinetics and Pharmacodynamics of CinnoVex (Interferon Beta-1a) Compared to Avonex (Interferon Beta-1a)

> **NCT03614715** · PHASE1 · COMPLETED · sponsor: **Cinnagen** · enrollment: 40 (actual)

## Conditions studied

- Bioequivalence
- Healthy

## Interventions

- **DRUG:** Interferon Beta-1A

## Key facts

- **NCT ID:** NCT03614715
- **Lead sponsor:** Cinnagen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-27
- **Primary completion:** 2019-02-12
- **Final completion:** 2019-02-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03614715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03614715, "Pharmacokinetics and Pharmacodynamics of CinnoVex (Interferon Beta-1a) Compared to Avonex (Interferon Beta-1a)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03614715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*